相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 询价记录
- 文献和实验
- 技术资料
- 免疫原:
Recombinant Human CMV gB / Glycoprotein B protein (Catalog#10202-V08H1)
- 亚型:
Mouse IgG1
- 形态:
液体
- 保存条件:
-20℃ to -80℃
- 克隆性:
鼠单抗
- 适应物种:
CMV
- 保质期:
12个月
- 抗原来源:
10202-V08H1
- 目录编号:
10202-MM02
- 级别:
免疫学试剂
- 库存:
99
- 供应商:
北京义翘神州科技股份有限公司
- 宿主:
Mouse
- 应用范围:
WB,ELISA
- 浓度:
WB: 1:1000-1:5000;ELISA: 1:1000-1:2000
- 靶点:
gB
- 抗体英文名:
Human cytomegalovirus (HCMV) Glycoprotein B / gB, Mouse MAb
- 抗体名:
巨细胞病毒糖蛋白B鼠单抗
- 规格:
20.00 µL/50.00 µL/100.00 µL
| 规格: | 20.00 µL | 产品价格: | ¥800.0 |
|---|---|---|---|
| 规格: | 50.00 µL | 产品价格: | ¥1500.0 |
| 规格: | 100.00 µL | 产品价格: | ¥2500.0 |
抗体种属:CMV
抗体靶点:gB
抗体应用:WB,ELISA
抗原货号:10202-V08H1
抗原描述:Recombinant Human CMV gB / Glycoprotein B protein (Catalog#10202-V08H1)
抗体宿主:Mouse
抗体Ig类型:Mouse IgG1
抗体纯化方法:Protein A
抗体制备:This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human CMV gB (Catalog#10202-V08H1; AAA45920.1) extracellular domain (Met 1-Lys 700) linked with the cytoplasmic domain (Arg 777-Val 907). The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography.
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
- 作者
- 内容
- 询问日期
文献和实验Applications for a Dual Fluorescent Human Cytomegalovirus in the Analysis of Viral Entry
The existence of cell type-specific entry pathways of human cytomegalovirus is an unresolved question as the course of viral entry in different cell types is still not fully understood. To gain more insight into these processes, we generated
关键词: 人类巨细胞病毒(HCMV) 系统性红斑狼疮(SLE) 免疫抑制 感染 人类巨细胞病毒(human cytomegalovirus,HCMV)在免疫抑制或免疫缺陷病人中常可引起活动性感染,导致各种临床综合征甚至致命性疾病。接受免疫抑制治疗的系统性红斑狼疮(systemic lupus erythematosus,SLE)患者是HCMV疾病的易患人群之一,本综述主要涉及HCMV感染的特点,SLE免疫抑制治疗的特性以及该人群中HCMV感染的临床表现、诊断、治疗及预防
and characterization of monoclonal antibodies against P-glycoprotein(Pgp) (抗P-GP单克隆抗体的制备和鉴定),Chin J Hematol(中国血液学杂志), 1999,20(6):326-327.[7] Yang C.Z., Luan F.J., Xiong D.S., Liu B.R., Xu Y.F., Gu K.S. Multidrug resistance in leukemiccell line K562/A02 induced
技术资料暂无技术资料 索取技术资料










